Log in or Sign up for Free to view tailored content for your specialty!
Neurology News
Prenatal air pollution exposure tied to increased risk for cerebral palsy
Prenatal exposure to ambient air pollution was associated with increased risk for children developing cerebral palsy, according to cohort study results published in JAMA Network Open.
Consider today’s options for covering the future cost of long-term care
As their parents age, many of our physician clients have asked us about long-term care insurance.
Log in or Sign up for Free to view tailored content for your specialty!
Taking soy protein before bed may improve sleep quality
CHICAGO — A higher intake of protein, particularly soy, a half-hour before bed was tied to improved sleep quality in older adults, according to the results of a study presented at NUTRITION.
Vistagen announces new patents for investigational pherine nasal spray to treat migraine
A clinical-stage neuroscience-focused biopharmaceutical company has received new international patents related to an investigational neuroactive pherine nasal spray to potentially treat individuals with migraine.
AI tools require precise language, content formulation to better assist medical education
AI-generative tools such as ChatGPT may be a useful tool for medical education but require precise formulation of language and content to match and assist skills of human counterparts, according to new research from Brain and Spine.
CMS proposes cutting physician payments for fifth straight year
CMS has released its proposed 2025 Medicare Physician Fee Schedule, or PFS, which includes a 2.93% cut in physician payments from the previous year, according to a press release.
No significant difference in clinical outcomes, recovery in college athletes with concussion
No significant differences were found in clinical outcomes or recovery time in college athletes who returned to play following concussion compared with those immediately removed, according to research from Neurosurgical Focus.
Disease progression slowed by 80% at 24 months in phase 1/2 studies of HD gene therapy
Interim results of phase 1/2 clinical trials of an investigational gene therapy for Huntington’s disease showed that disease progression slowed by 80% at 24 months, according to the manufacturer.
Brain stimulation may have distinct near-maximal effective doses across mental disorders
Significant dose-response associations were found for transcranial magnetic stimulation and transcranial direct current stimulation across several mental disorders, including schizophrenia and depression, according to research.
Interim phase 1/2a study results positive for investigational Parkinson’s cell therapy
A South Korean biomedical company has announced positive 1-year assessment data from a phase 1/2a clinical trial of a human embryonic stem cell-derived midbrain dopaminergic progenitor for Parkinson’s disease.
-
Headline News
FDA warns of potential liver injury with Veozah for menopausal hot flashes
September 12, 20242 min read -
Headline News
Video games improved mental health during COVID-19 pandemic
September 12, 20242 min read -
Headline NewsSeptember 12, 20240 min read
-
Headline News
FDA warns of potential liver injury with Veozah for menopausal hot flashes
September 12, 20242 min read -
Headline News
Video games improved mental health during COVID-19 pandemic
September 12, 20242 min read -
Headline NewsSeptember 12, 20240 min read